Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (121-130 of 308) with videos related to

Pageof 31
Sort By:
Allergologie Select|December 25, 2023
DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapyOliver Pfaar, Eckard Hamelmann, Christian Taube, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 4, 2024
Allergen Immunotherapy for the Prevention and Treatment of AsthmaThierry Batard, Camille Taillé, Laurent Guilleminault, et al.
The World Allergy Organization Journal|December 30, 2020
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patientsKarl-Christian Bergmann, Linda Krause, Julia Hiller, et al.
Clinical and Translational Allergy|April 29, 2015
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocolMelina Makatsori, Gianenrico Senna, Constantinos Pitsios, et al.
Allergologie Select|April 12, 2021
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie Select|September 17, 2021
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 22, 2022
Automatic market research of mobile health apps for the self-management of allergic rhinitisAram Antó, Bernardo Sousa-Pinto, Wienczyslawa Czarlewski, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|August 16, 2021
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 12, 2026
Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatricsPhilippe Devillier, Mitsuhiro Okano, Giorgio Walter Canonica, et al.
Journal of Clinical Medicine|December 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo TreatmentSandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar, et al.
Pageof 31

Showing results (121-130 of 308) with videos related to

Sort By:
Pageof 31
Allergologie Select|December 25, 2023
DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapyOliver Pfaar, Eckard Hamelmann, Christian Taube, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 4, 2024
Allergen Immunotherapy for the Prevention and Treatment of AsthmaThierry Batard, Camille Taillé, Laurent Guilleminault, et al.
The World Allergy Organization Journal|December 30, 2020
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patientsKarl-Christian Bergmann, Linda Krause, Julia Hiller, et al.
Clinical and Translational Allergy|April 29, 2015
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocolMelina Makatsori, Gianenrico Senna, Constantinos Pitsios, et al.
Allergologie Select|April 12, 2021
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie Select|September 17, 2021
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 22, 2022
Automatic market research of mobile health apps for the self-management of allergic rhinitisAram Antó, Bernardo Sousa-Pinto, Wienczyslawa Czarlewski, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|August 16, 2021
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 12, 2026
Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatricsPhilippe Devillier, Mitsuhiro Okano, Giorgio Walter Canonica, et al.
Journal of Clinical Medicine|December 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo TreatmentSandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar, et al.
Pageof 31